152 related articles for article (PubMed ID: 2196280)
1. H-ras protooncogene mutations in human thyroid neoplasms.
Namba H; Gutman RA; Matsuo K; Alvarez A; Fagin JA
J Clin Endocrinol Metab; 1990 Jul; 71(1):223-9. PubMed ID: 2196280
[TBL] [Abstract][Full Text] [Related]
2. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
3. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma].
Taniyama M; Kaihara M
Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166
[TBL] [Abstract][Full Text] [Related]
4. Specific PCR amplification for N-ras mutations in neoplastic thyroid diseases.
Kaihara M; Taniyama M; Tadatomo J; Tobe T; Tomita M; Ito K; Ban Y; Katagiri T
Endocr J; 1994 Jun; 41(3):301-8. PubMed ID: 7951583
[TBL] [Abstract][Full Text] [Related]
5. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
Bouras M; Parvaz P; Berger N; Paulin C; Revol A
Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
[TBL] [Abstract][Full Text] [Related]
7. Point mutations of ras and Gs alpha subunit genes in thyroid tumors.
Horie H; Yokogoshi Y; Tsuyuguchi M; Saito S
Jpn J Cancer Res; 1995 Aug; 86(8):737-42. PubMed ID: 7559096
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
[TBL] [Abstract][Full Text] [Related]
9. Ras oncogene mutations in benign and malignant thyroid neoplasms.
Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
[TBL] [Abstract][Full Text] [Related]
10. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
11. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
[TBL] [Abstract][Full Text] [Related]
12. Presence of mutations in all three ras genes in human thyroid tumors.
Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
[TBL] [Abstract][Full Text] [Related]
13. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
14. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
[TBL] [Abstract][Full Text] [Related]
15. Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.
Capella G; Matias-Guiu X; Ampudia X; de Leiva A; Perucho M; Prat J
Diagn Mol Pathol; 1996 Mar; 5(1):45-52. PubMed ID: 8919545
[TBL] [Abstract][Full Text] [Related]
16. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
17. Specific pattern of RAS oncogene mutations in follicular thyroid tumors.
Vasko V; Ferrand M; Di Cristofaro J; Carayon P; Henry JF; de Micco C
J Clin Endocrinol Metab; 2003 Jun; 88(6):2745-52. PubMed ID: 12788883
[TBL] [Abstract][Full Text] [Related]
18. H-ras mutations in human pituitary carcinoma metastases.
Pei L; Melmed S; Scheithauer B; Kovacs K; Prager D
J Clin Endocrinol Metab; 1994 Apr; 78(4):842-6. PubMed ID: 8157709
[TBL] [Abstract][Full Text] [Related]
19. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
20. Ras gene mutation and amplification in human nonmelanoma skin cancers.
Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
